News & Views
Kolia to Head Business Development at Ark
Jun 28 2012
Ark Therapeutics Group plc has appointed Kassim Kolia, BSc (Hons), as Head of Business Development, with responsibility for building the company’s manufacturing services business at its viral process development and manufacturing facility based in Kuopio, Finland.
Kassim joins Ark from Eden Biodesign Ltd where he led business progression of its contract development and manufacturing services. He was previously Key Account Manager at Bachem (UK) Ltd where he was responsible for business development of cGMP business opportunities for the company in the UK and Ireland. Prior to that, Kassim held the role of cGMP Line Manager at Lonza Biologics where he was responsible for the day-to-day running of the manufacturing plant.
In this role, Kassim reports directly to Dr David Venables, Executive Director – Manufacturing Services who said: “Kassim’s extensive experience in winning manufacturing service contracts will enable us to accelerate the development of our world-leading contract viral product development and manufacturing services capability into a major, self-sustaining business. I look forward to working with him at what is a very exciting time for Ark.”
Digital Edition
LMUK 49.7 Nov 2024
November 2024
News - Research & Events News - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...
View all digital editions
Events
Nov 11 2024 Dusseldorf, Germany
Nov 12 2024 Cologne, Germany
Nov 12 2024 Tel Aviv, Israel
Nov 18 2024 Shanghai, China
Nov 20 2024 Karachi, Pakistan